[1]
H. Reikvam, “LOW INCIDENCE OF ANTI-PF4/HEPARIN ANTIBODIES IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA ”, Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024057, Jun. 2024.